Page 1 of Clinical Trials for "Neoplasms, Plasma Cell", 1521 Total Matches
- 1Active, not recruitingLast Updated: May 17, 2012Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 2CompletedLast Updated: March 1, 2007Condition(s): Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
- 3Active, not recruitingLast Updated: March 23, 2012Condition(s): Refractory Multiple Myeloma; Smoldering Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 4Active, not recruitingLast Updated: January 5, 2012Condition(s): Multiple Myeloma; Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 5RecruitingLast Updated: January 4, 2012Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 6Active, not recruitingLast Updated: March 7, 2011Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 7RecruitingLast Updated: April 18, 2012Condition(s): Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 8Active, not recruitingLast Updated: February 29, 2012Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 9WithdrawnLast Updated: December 4, 2006Condition(s): Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
- 10TerminatedLast Updated: January 24, 2012Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 11RecruitingLast Updated: January 9, 2012Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 12Active, not recruitingLast Updated: July 29, 2011Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 13RecruitingLast Updated: January 17, 2012Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 14Active, not recruitingLast Updated: December 13, 2011Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 15RecruitingLast Updated: March 28, 2012Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 16Active, not recruitingLast Updated: November 23, 2011Condition(s): Relapsed and Bortezomib Refractory Multiple Myeloma; Refractory Multiple Myeloma; Relapsed Multiple Myeloma
- 17RecruitingLast Updated: April 4, 2012Condition(s): Multiple Myeloma; Multiple Myeloma in Relapse; Refractory Multiple Myeloma
- 18RecruitingLast Updated: January 23, 2012Condition(s): Multiple Myeloma; Relapsed Multiple Myeloma; Refractory Multiple Myeloma
- 19CompletedLast Updated: June 8, 2011Condition(s): Multiple Myeloma; Myeloma; M-Protein; Myeloma Proteins
- 20Active, not recruitingLast Updated: April 29, 2009Condition(s): Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Neoplasms%2C+Plasma+Cell%22
